Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Dermatologic 1CNS 1Breast 1

Conditions

Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Penile Neoplasms 1Oropharyngeal Neoplasms 1Neoplasm Metastasis 1Metastatic Solid Tumors 1Melanoma 1Lung Neoplasms 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1Anus Neoplasms 1

Interventions

Specimen Handling 53pembrolizumab 51Carboplatin 51Magnetic Resonance Spectroscopy 46Pemetrexed 41Cisplatin 36Paclitaxel 25durvalumab 24osimertinib 22Nivolumab 22Gemcitabine 20Radiosurgery 18Radiotherapy 17Docetaxel 17atezolizumab 15Immunoglobulin G 15Biopsy 15Disulfides 14130-nm albumin-bound paclitaxel 13Taxes 12Radiation 12Educational Status 12Etoposide 11Blood Specimen Collection 11Early Intervention, Educational 10Drug Therapy 10Practice Guidelines as Topic 9Platinum 9Methods 9Cetuximab 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Neoplasms × bintrafusp alfa protein, human × 90 days × Clear all
NCT04789668 2026-03-18

Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases

M.D. Anderson Cancer Center

Phase 1/2 Terminated
8 enrolled 13 charts
BreastCNSDermatologicOther hematologic neoplasmThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Hematologic Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡